首页 > 最新文献

European Journal of Clinical Investigation最新文献

英文 中文
Mental stress as a trigger of cardiovascular events: A narrative review 精神压力作为心血管事件的触发因素:一个叙述性回顾。
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-30 DOI: 10.1111/eci.70128
Paolo Raggi

Background

Several mental disorders has been associated with cardiovascular disease (CVD), although stress may have the strongest correlation. In this narrative review, we examine how stress is linked to CVD.

Results

Stress can be secondary to multiple factors and it can be imposed on an individual in more or less manifest ways. Psychosocial stress can result from adverse social circumstances such as poverty, racial, gender, religious disparities or discrimination, violence and environmental pollution. Large segments of the population are forced to endure poor working conditions, low food quality, physical and verbal abuse not only in the developing world but also in more flourishing societies as well. Wars that have ignited widely of late are inherently stressful events with potential enduring effects after the conflicts. Isolation and loneliness are growing issues in modern societies and impose a heavy burden of stress. Epidemiological studies have shown that stress is linked to CVD through an increased incidence of traditional risk factors (smoking, hypertension, insulin resistance and obesity). Experimental and laboratory evidence has shown a link between stress and CVD via neuro-endocrine, inflammatory and immune pathways. Patients with prior CV events affected by stress are at higher risk of recurrent events compared to similar patients without stressful conditions.

Conclusions

The close association between stress and CVD suggests that interventions to limit the effect of stress may result in a reduced incidence of de novo and recurrent CV events. Physicians should be aware of the importance of screening for stress in patients with CVD. Future efforts should be directed to the development of easily implementable screening tools and targeted interventions within healthcare frameworks.

背景:一些精神障碍与心血管疾病(CVD)有关,尽管压力可能有最强的相关性。在这篇叙述性综述中,我们研究了压力是如何与心血管疾病联系在一起的。结果:压力可以是次要的多种因素,它可以施加在个人或多或少的显着方式。社会心理压力可由不利的社会环境造成,如贫穷、种族、性别、宗教差异或歧视、暴力和环境污染。不仅在发展中国家,而且在更繁荣的社会,很大一部分人口被迫忍受恶劣的工作条件、低质量的食物、身体和语言虐待。最近广泛爆发的战争本质上是紧张事件,在冲突结束后可能会产生持久的影响。孤立和孤独是现代社会日益严重的问题,给人带来沉重的压力。流行病学研究表明,压力通过增加传统风险因素(吸烟、高血压、胰岛素抵抗和肥胖)的发生率与心血管疾病有关。实验和实验室证据表明,压力与心血管疾病之间存在神经内分泌、炎症和免疫途径的联系。既往CV事件受压力影响的患者与无压力条件的类似患者相比,复发事件的风险更高。结论:压力与心血管疾病之间的密切联系表明,限制压力影响的干预措施可能会降低新生和复发性心血管事件的发生率。医生应该意识到心血管疾病患者压力筛查的重要性。今后的工作应着眼于在保健框架内开发易于实施的筛查工具和有针对性的干预措施。
{"title":"Mental stress as a trigger of cardiovascular events: A narrative review","authors":"Paolo Raggi","doi":"10.1111/eci.70128","DOIUrl":"10.1111/eci.70128","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Several mental disorders has been associated with cardiovascular disease (CVD), although stress may have the strongest correlation. In this narrative review, we examine how stress is linked to CVD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Stress can be secondary to multiple factors and it can be imposed on an individual in more or less manifest ways. Psychosocial stress can result from adverse social circumstances such as poverty, racial, gender, religious disparities or discrimination, violence and environmental pollution. Large segments of the population are forced to endure poor working conditions, low food quality, physical and verbal abuse not only in the developing world but also in more flourishing societies as well. Wars that have ignited widely of late are inherently stressful events with potential enduring effects after the conflicts. Isolation and loneliness are growing issues in modern societies and impose a heavy burden of stress. Epidemiological studies have shown that stress is linked to CVD through an increased incidence of traditional risk factors (smoking, hypertension, insulin resistance and obesity). Experimental and laboratory evidence has shown a link between stress and CVD via neuro-endocrine, inflammatory and immune pathways. Patients with prior CV events affected by stress are at higher risk of recurrent events compared to similar patients without stressful conditions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The close association between stress and CVD suggests that interventions to limit the effect of stress may result in a reduced incidence of de novo and recurrent CV events. Physicians should be aware of the importance of screening for stress in patients with CVD. Future efforts should be directed to the development of easily implementable screening tools and targeted interventions within healthcare frameworks.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"56 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145198840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The intergenerational effects of low parental socio-economic position on cardiometabolic and inflammatory outcomes: A systematic review and meta-analysis 父母低社会经济地位对心脏代谢和炎症结果的代际影响:系统回顾和荟萃分析。
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-29 DOI: 10.1111/eci.70125
Juan Carlos Rivillas-García, Emilie Courtin, Eleanor Winpenny, Olaide Adebayo-Clement, Raúl Devia-Rodríguez, Ornella Moreno-Mattar, Paolo Vineis

Background

Evidence on the impacts of parental and early life socio-economic position (SEP) on health outcomes in adulthood remains mixed. This systematic review and meta-analysis investigated the association between low parental SEP and adult cardiometabolic and inflammatory markers in individuals aged 18 years and older.

Methods

A systematic search across five databases (EMBASE, Ovid MEDLINE, Cinahl, Global Health and Maternity and Infant Care until January 01, 2022) identified observational studies linking parental SEP with adult cardiometabolic and inflammatory markers. Pooled Standardized Mean Differences (SMD) were estimated using random-effects models. Risk of bias, heterogeneity and publication bias were assessed using the Cochrane tool, subgroup analysis and Egger's test, respectively.

Results

The review included 38 studies (12 in meta-analysis, n = 388,674). Findings showed that lower parental SEP was significantly associated with elevated blood pressure (SMD = .30 mmHg; 95% CI: .10, .50; I2 94%; n = 5), increased adiposity (SMD = .56; 95% CI: .05, 1.07: I2 98%; n = 6), higher C-reactive protein levels (SMD = 1.45 mg/dL; 95% CI: .06, 2.85; I2 80%; n = 9), elevated IL-6 (SMD = 2.12 pg./mL; 95% CI: −.72, 4.97; I2 100%; n = 4) and higher allostatic load (SMD = .85; 95% CI: .30, 1.40; I2 99%; n = 4). No consistent associations were found for glucose or lipid markers. Gender-specific variations were observed.

Conclusions

Low parental socio-economic position negatively impacts adult offspring health, manifesting as higher blood pressure, elevated C-reactive protein, increased interleukin-6, greater adiposity and higher allostatic load. Future research should prioritise three critical areas: mechanistic specificity, intersectional pathways and life-course timing and critical period detection.

背景:关于父母和早期生活社会经济地位(SEP)对成年期健康结果影响的证据仍然是混合的。本系统综述和荟萃分析调查了父母低SEP与18岁及以上成人心脏代谢和炎症标志物之间的关系。方法:系统检索5个数据库(EMBASE、Ovid MEDLINE、Cinahl、Global Health和妇幼保健,截止2022年1月1日),确定观察性研究将父母SEP与成人心脏代谢和炎症标志物联系起来。使用随机效应模型估计合并标准化平均差异(SMD)。分别采用Cochrane工具、亚组分析和Egger检验评估偏倚风险、异质性和发表偏倚。结果:纳入38项研究(12项荟萃分析,n = 388,674)。结果显示,父母低SEP与血压升高显著相关(SMD = 0.30 mmHg; 95% CI:。10、50;I2 94%;n = 5),肥胖增加(SMD = 0.56; 95% CI:。05, 1.07: i2 98%;n = 6),较高的c反应蛋白水平(SMD = 1.45 mg/dL; 95% CI:。06年,2.85;I2 80%;n = 9), IL-6升高(SMD = 2.12 pg./mL; 95% CI: - 0.72, 4.97; I2 100%; n = 4)和更高的适应负荷(SMD = 0.85; 95% CI:。30日,1.40;I2 99%;n = 4)。没有发现葡萄糖或脂质标记物的一致关联。观察到性别差异。结论:父母社会经济地位低会对成年后代的健康产生负面影响,表现为血压升高、c反应蛋白升高、白细胞介素-6升高、肥胖和适应负荷增加。未来的研究应优先考虑三个关键领域:机制特异性、交叉通路和生命过程定时和关键时期检测。
{"title":"The intergenerational effects of low parental socio-economic position on cardiometabolic and inflammatory outcomes: A systematic review and meta-analysis","authors":"Juan Carlos Rivillas-García,&nbsp;Emilie Courtin,&nbsp;Eleanor Winpenny,&nbsp;Olaide Adebayo-Clement,&nbsp;Raúl Devia-Rodríguez,&nbsp;Ornella Moreno-Mattar,&nbsp;Paolo Vineis","doi":"10.1111/eci.70125","DOIUrl":"10.1111/eci.70125","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Evidence on the impacts of parental and early life socio-economic position (SEP) on health outcomes in adulthood remains mixed. This systematic review and meta-analysis investigated the association between low parental SEP and adult cardiometabolic and inflammatory markers in individuals aged 18 years and older.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A systematic search across five databases (EMBASE, Ovid MEDLINE, Cinahl, Global Health and Maternity and Infant Care until January 01, 2022) identified observational studies linking parental SEP with adult cardiometabolic and inflammatory markers. Pooled Standardized Mean Differences (SMD) were estimated using random-effects models. Risk of bias, heterogeneity and publication bias were assessed using the Cochrane tool, subgroup analysis and Egger's test, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The review included 38 studies (12 in meta-analysis, <i>n</i> = 388,674). Findings showed that lower parental SEP was significantly associated with elevated blood pressure (SMD = .30 mmHg; 95% CI: .10, .50; <i>I</i><sup>2</sup> 94%; <i>n</i> = 5), increased adiposity (SMD = .56; 95% CI: .05, 1.07: <i>I</i><sup>2</sup> 98%; <i>n</i> = 6), higher C-reactive protein levels (SMD = 1.45 mg/dL; 95% CI: .06, 2.85; <i>I</i><sup>2</sup> 80%; <i>n</i> = 9), elevated IL-6 (SMD = 2.12 pg./mL; 95% CI: −.72, 4.97; <i>I</i><sup>2</sup> 100%; <i>n</i> = 4) and higher allostatic load (SMD = .85; 95% CI: .30, 1.40; <i>I</i><sup>2</sup> 99%; <i>n</i> = 4). No consistent associations were found for glucose or lipid markers. Gender-specific variations were observed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Low parental socio-economic position negatively impacts adult offspring health, manifesting as higher blood pressure, elevated C-reactive protein, increased interleukin-6, greater adiposity and higher allostatic load. Future research should prioritise three critical areas: mechanistic specificity, intersectional pathways and life-course timing and critical period detection.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"56 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12817245/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PD-L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single-center retrospective study PD-L1表达模式作为颅内脑膜瘤生物学行为的预测因素:一项单中心回顾性研究。
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-24 DOI: 10.1111/eci.70124
Gabriele Gaggero, Alessandro Pesaresi, Debora Giunti, Andrea Bianconi, Monica Truffelli, Massimiliano Grassi, Luca Valle, Sharon Duzioni, Paolo Nozza, Mariella Dono, Giorgia Anselmi, Gianluigi Zona, Valerio Vellone, Pietro Fiaschi

Background

Molecular expression of meningiomas has become increasingly important for predicting their biological behaviour. However, the factors influencing tumour recurrence and progression after surgery remain unclear. Recent studies suggest that programmed death-ligand 1 (PD-L1) could be a key predictive and therapeutic factor in these tumours.

Methods

This single-center retrospective study included 96 patients who underwent Simpson Grade I resection of intracranial meningiomas between 2001 and 2022. PD-L1 expression was assessed immunohistochemically (clone SP142) and categorized as overall (OE), membranous (mb), granular cytoplasmic (gr) and perinuclear dot-like. Associations with WHO grade, recurrence, mitotic count and Ki-67 index were analysed using univariate and multivariate statistics.

Results

118 samples were analysed. Grade 2 meningiomas showed significantly higher mitotic count (4.0 ± 5.5 vs. 1.0 ± 1.0 n/mm2, p < .001) and Ki-67 index (7.6 ± 2.1% vs. 3.5 ± .2%, p < .001) than Grade 1. PD-L1 OE (2.0 ± 5.0% vs. .0 ± 1.0%, p < .001), gr (1.0 ± 2.5% vs. .0 ± 1.0%, p < .001) and mb (1.0 ± 1.0% vs. .0 ± .0%, p = .003) expressions were also higher in Grade 2. At recurrence, Grade 1 tumours progressing to Grade 2 showed increased PD-L1 OE (p = .025), gr (p = .024) and mb (p = .037). Multivariate analysis confirmed PD-L1 gr and mb as independent markers of high-grade tumours.

Conclusions

Granular cytoplasmic and membranous PD-L1 expression patterns are significantly associated with tumour grade, recurrence and progression, suggesting their potential role as prognostic biomarkers in meningiomas.

背景:脑膜瘤的分子表达在预测其生物学行为方面变得越来越重要。然而,影响术后肿瘤复发和进展的因素仍不清楚。最近的研究表明,程序性死亡配体1 (PD-L1)可能是这些肿瘤的关键预测和治疗因素。方法:这项单中心回顾性研究纳入了2001年至2022年间96例接受Simpson I级颅内脑膜瘤切除术的患者。免疫组织化学检测PD-L1的表达(克隆SP142),并将其分为整体(OE)、膜状(mb)、颗粒状细胞质(gr)和核周点状。采用单因素和多因素统计分析与WHO分级、复发率、有丝分裂计数和Ki-67指数的关系。结果:对118份样品进行了分析。2级脑膜瘤有丝分裂计数(4.0±5.5 vs. 1.0±1.0 n/mm2)显著高于2级脑膜瘤(4.0±5.5 vs. 1.0±1.0 n/mm2)。结论:颗粒状细胞质和膜质PD-L1表达模式与肿瘤分级、复发和进展显著相关,提示其作为脑膜瘤预后生物标志物的潜在作用。
{"title":"PD-L1 expression pattern as predictive factor of biological behaviour in intracranial meningiomas: A single-center retrospective study","authors":"Gabriele Gaggero,&nbsp;Alessandro Pesaresi,&nbsp;Debora Giunti,&nbsp;Andrea Bianconi,&nbsp;Monica Truffelli,&nbsp;Massimiliano Grassi,&nbsp;Luca Valle,&nbsp;Sharon Duzioni,&nbsp;Paolo Nozza,&nbsp;Mariella Dono,&nbsp;Giorgia Anselmi,&nbsp;Gianluigi Zona,&nbsp;Valerio Vellone,&nbsp;Pietro Fiaschi","doi":"10.1111/eci.70124","DOIUrl":"10.1111/eci.70124","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Molecular expression of meningiomas has become increasingly important for predicting their biological behaviour. However, the factors influencing tumour recurrence and progression after surgery remain unclear. Recent studies suggest that programmed death-ligand 1 (PD-L1) could be a key predictive and therapeutic factor in these tumours.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This single-center retrospective study included 96 patients who underwent Simpson Grade I resection of intracranial meningiomas between 2001 and 2022. PD-L1 expression was assessed immunohistochemically (clone SP142) and categorized as overall (OE), membranous (mb), granular cytoplasmic (gr) and perinuclear dot-like. Associations with WHO grade, recurrence, mitotic count and Ki-67 index were analysed using univariate and multivariate statistics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>118 samples were analysed. Grade 2 meningiomas showed significantly higher mitotic count (4.0 ± 5.5 vs. 1.0 ± 1.0 n/mm<sup>2</sup>, <i>p</i> &lt; .001) and Ki-67 index (7.6 ± 2.1% vs. 3.5 ± .2%, <i>p</i> &lt; .001) than Grade 1. PD-L1 OE (2.0 ± 5.0% vs. .0 ± 1.0%, <i>p</i> &lt; .001), gr (1.0 ± 2.5% vs. .0 ± 1.0%, <i>p</i> &lt; .001) and mb (1.0 ± 1.0% vs. .0 ± .0%, <i>p</i> = .003) expressions were also higher in Grade 2. At recurrence, Grade 1 tumours progressing to Grade 2 showed increased PD-L1 OE (<i>p</i> = .025), gr (<i>p</i> = .024) and mb (<i>p</i> = .037). Multivariate analysis confirmed PD-L1 gr and mb as independent markers of high-grade tumours.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Granular cytoplasmic and membranous PD-L1 expression patterns are significantly associated with tumour grade, recurrence and progression, suggesting their potential role as prognostic biomarkers in meningiomas.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"56 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145130451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Central nervous system involvement in cardiac amyloidosis: Redefining the heart-brain axis 心脏淀粉样变涉及中枢神经系统:重新定义心脑轴。
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-23 DOI: 10.1111/eci.70122
Domenico Mario Giamundo, Giuliano Cassataro, Stefano Ministrini, Simon F. Stämpfli

Background

Amyloidosis is characterised by the extracellular accumulation of misfolded proteins forming amorphous aggregates called amyloid. Cardiac amyloidosis results from myocardial involvement in systemic amyloidosis, leading to impaired heart function. Besides myocardial involvement, cardiac amyloidosis may also directly and indirectly affect the central nervous system.

Methods

This narrative review summarises current evidence about on central nervous system involvement in cardiac amyloidosis and the pathophysiological mechanisms linking heart and brain in the context of this systemic disease.

Results

Although the pathophysiological relationship between cardiac amyloidosis and cognitive decline remains poorly understood, central nervous system involvement likely results from the complex interplay of direct amyloid deposition, cerebrovascular changes, and cardiac dysfunction.

Conclusion

The growing awareness of cognitive impairment in patients with cardiac amyloidosis highlights the need for further research and supports a multidisciplinary approach in the assessment and management of affected individuals.

背景:淀粉样变性的特征是细胞外积聚错误折叠的蛋白质,形成无定形的聚集体,称为淀粉样蛋白。心脏淀粉样变性是由心肌累及全身淀粉样变性引起的,导致心功能受损。除心肌受累外,心肌淀粉样变还可直接或间接影响中枢神经系统。方法:本文综述了目前关于中枢神经系统参与心脏淀粉样变的证据,以及在这种全身性疾病背景下心脏和大脑联系的病理生理机制。结果:尽管心脏淀粉样变性和认知能力下降之间的病理生理关系尚不清楚,但中枢神经系统的受累可能是淀粉样蛋白直接沉积、脑血管改变和心功能障碍的复杂相互作用的结果。结论:对心脏淀粉样变性患者认知功能障碍的认识日益提高,表明需要进一步研究,并支持对受影响个体进行多学科评估和管理。
{"title":"Central nervous system involvement in cardiac amyloidosis: Redefining the heart-brain axis","authors":"Domenico Mario Giamundo,&nbsp;Giuliano Cassataro,&nbsp;Stefano Ministrini,&nbsp;Simon F. Stämpfli","doi":"10.1111/eci.70122","DOIUrl":"10.1111/eci.70122","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Amyloidosis is characterised by the extracellular accumulation of misfolded proteins forming amorphous aggregates called amyloid. Cardiac amyloidosis results from myocardial involvement in systemic amyloidosis, leading to impaired heart function. Besides myocardial involvement, cardiac amyloidosis may also directly and indirectly affect the central nervous system.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This narrative review summarises current evidence about on central nervous system involvement in cardiac amyloidosis and the pathophysiological mechanisms linking heart and brain in the context of this systemic disease.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Although the pathophysiological relationship between cardiac amyloidosis and cognitive decline remains poorly understood, central nervous system involvement likely results from the complex interplay of direct amyloid deposition, cerebrovascular changes, and cardiac dysfunction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The growing awareness of cognitive impairment in patients with cardiac amyloidosis highlights the need for further research and supports a multidisciplinary approach in the assessment and management of affected individuals.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"56 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811839/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine learning-based prediction of atrial fibrillation in patients with atrial high-rate episodes 基于机器学习的心房颤动高发生率发作患者预测。
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-14 DOI: 10.1111/eci.70121
Amir Askarinejad, Tommaso Bucci, Niloofar Asgharzadeh, Zahra Amirjam, Enrico Tartaglia, Michele Rossi, Yang Chen, Yalin Zheng, Gregory Y. H. Lip, Majid Haghjoo

Background

Given the modest performance of available predictive models in estimating the risk of atrial fibrillation (AF) in patients with atrial high-rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs), this study explores the potential use of machine learning (ML) algorithms in this context.

Purpose

To assess the ability of ML techniques in identifying patients with AHRE at high risk of AF.

Methods

In this prospective study, we enrolled patients without a prior history of AF who experienced at least one AHRE episode detected by CIEDs. ML techniques were applied to predict the 1-year risk of developing new-onset AF based on the following variables: age, BMI, sex, smoking, hypertension, diabetes, coronary artery disease, chronic kidney disease, dyslipidaema, history of stroke or transient ischaemic attack, vascular heart disease, left atrial enlargement (LAE) and congestive heart failure.

Results

Study population consists of 100 patients (48% male, mean age 66.0 ± 18.0 years), of whom 24 developed AF (24%) after 1-year follow-up. The CatBoost ML model achieved the highest AUC (.857, 95% CI .671–.999) when compared to other ML models and all clinical risk scores. The top four most influential predictors of AF in the CatBoost model were LAE, hypertension, diabetes and age.

Conclusions

ML techniques are robust in predicting AF in patients with AHREs. Further validation in larger, independent cohorts is warranted.

背景:鉴于可用的预测模型在估计心房高频率发作(AHREs)患者心房颤动(AF)风险方面的适度表现,本研究探讨了机器学习(ML)算法在这方面的潜在应用。目的:评估ML技术识别AF高风险AHRE患者的能力。方法:在这项前瞻性研究中,我们招募了没有AF病史且至少经历过一次cied检测到的AHRE发作的患者。基于以下变量,应用ML技术预测1年内发生新发房颤的风险:年龄、BMI、性别、吸烟、高血压、糖尿病、冠状动脉疾病、慢性肾脏疾病、血脂异常、中风或短暂性缺血发作史、血管性心脏病、左房扩大(LAE)和充血性心力衰竭。结果:研究人群包括100例患者(男性48%,平均年龄66.0±18.0岁),随访1年后发生房颤24例(24%)。CatBoost ML模型获得了最高的AUC(。857, 95% CI .671-.999),与其他ML模型和所有临床风险评分相比。在CatBoost模型中,对房颤影响最大的4个预测因子是LAE、高血压、糖尿病和年龄。结论:ML技术在预测AHREs患者房颤方面是可靠的。需要在更大的独立队列中进一步验证。
{"title":"Machine learning-based prediction of atrial fibrillation in patients with atrial high-rate episodes","authors":"Amir Askarinejad,&nbsp;Tommaso Bucci,&nbsp;Niloofar Asgharzadeh,&nbsp;Zahra Amirjam,&nbsp;Enrico Tartaglia,&nbsp;Michele Rossi,&nbsp;Yang Chen,&nbsp;Yalin Zheng,&nbsp;Gregory Y. H. Lip,&nbsp;Majid Haghjoo","doi":"10.1111/eci.70121","DOIUrl":"10.1111/eci.70121","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Given the modest performance of available predictive models in estimating the risk of atrial fibrillation (AF) in patients with atrial high-rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs), this study explores the potential use of machine learning (ML) algorithms in this context.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>To assess the ability of ML techniques in identifying patients with AHRE at high risk of AF.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this prospective study, we enrolled patients without a prior history of AF who experienced at least one AHRE episode detected by CIEDs. ML techniques were applied to predict the 1-year risk of developing new-onset AF based on the following variables: age, BMI, sex, smoking, hypertension, diabetes, coronary artery disease, chronic kidney disease, dyslipidaema, history of stroke or transient ischaemic attack, vascular heart disease, left atrial enlargement (LAE) and congestive heart failure.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Study population consists of 100 patients (48% male, mean age 66.0 ± 18.0 years), of whom 24 developed AF (24%) after 1-year follow-up. The CatBoost ML model achieved the highest AUC (.857, 95% CI .671–.999) when compared to other ML models and all clinical risk scores. The top four most influential predictors of AF in the CatBoost model were LAE, hypertension, diabetes and age.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>ML techniques are robust in predicting AF in patients with AHREs. Further validation in larger, independent cohorts is warranted.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"56 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811835/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145063550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OXPHOS complex deficiency in congenital myopathy: A systematic review 先天性肌病中OXPHOS复合物缺乏:一项系统综述。
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-11 DOI: 10.1111/eci.70114
Megan J. du Preez, Maryke Schoonen, Monray E. Williams, Michelle Bisschoff, Francois H. van der Westhuizen

Background

Congenital myopathies are inherited neuromuscular disorders characterized by early-onset muscle weakness and distinct histopathological features. Although mitochondrial involvement in congenital myopathy is well recognized in its pathophysiology, oxidative phosphorylation (OXPHOS) complex dysfunction, which is associated with primary mitochondrial diseases (MD), is not. This systematic review aimed to evaluate the prevalence and characteristics of reported OXPHOS complex dysfunction in genetically confirmed congenital myopathy cases.

Methods

A systematic literature search was conducted in PubMed, Scopus and Web of Science. The search strategy was developed according to PRISMA guidelines. Two independent reviewers screened the studies for inclusion. Eligible studies reported genetically confirmed congenital myopathy cases or disease models and included diagnostic OXPHOS complex analyses via enzyme kinetic assays and/or protein/RNA expression.

Results

Of 5841 studies screened, 23 publications (2009–2025) met the inclusion criteria, comprising 45 congenital myopathy cases. OXPHOS complex dysfunction was reported in 78% of these cases, including all human cases where OXPHOS enzymology was performed. Nine congenital myopathy-associated genes were involved in the cases, with RYR1 being the most frequent. No definitive genotype–phenotype relationship was established between specific genes and affected complexes.

Conclusions

OXPHOS complex dysfunction in congenital myopathy appears to be more prevalent than previously recognized, challenging the traditional view that associates such dysfunction exclusively with MD. This emerging evidence suggests that mitochondrial involvement in congenital myopathy is not incidental but may represent a meaningful aspect of its pathophysiology. The potential dysregulation of OXPHOS in congenital myopathy has implications for refining diagnostic frameworks for both congenital myopathy and MD.

背景:先天性肌病是一种以早发性肌肉无力和明显的组织病理学特征为特征的遗传性神经肌肉疾病。虽然线粒体参与先天性肌病在病理生理学上得到了很好的认识,但与原发性线粒体疾病(MD)相关的氧化磷酸化(OXPHOS)复合物功能障碍却没有得到很好的认识。本系统综述旨在评估遗传证实的先天性肌病病例中报告的OXPHOS复杂功能障碍的患病率和特征。方法:系统检索PubMed、Scopus和Web of Science的文献。搜索策略是根据PRISMA指南制定的。两名独立审稿人筛选了纳入的研究。符合条件的研究报告了遗传证实的先天性肌病病例或疾病模型,并包括通过酶动力学测定和/或蛋白质/RNA表达进行诊断OXPHOS复合物分析。结果:在筛选的5841项研究中,23篇出版物(2009-2025)符合纳入标准,包括45例先天性肌病病例。这些病例中有78%报告了OXPHOS复杂功能障碍,包括所有进行OXPHOS酶学研究的人类病例。9个先天性肌病相关基因与病例有关,其中RYR1最为常见。特异性基因和受影响的复合物之间没有确定的基因型-表型关系。结论:先天性肌病中的OXPHOS复合物功能障碍似乎比以前认识到的更为普遍,挑战了将这种功能障碍仅与MD联系在一起的传统观点。这一新证据表明,线粒体参与先天性肌病不是偶然的,而是其病理生理学的一个有意义的方面。先天性肌病中OXPHOS的潜在失调对完善先天性肌病和MD的诊断框架具有重要意义。
{"title":"OXPHOS complex deficiency in congenital myopathy: A systematic review","authors":"Megan J. du Preez,&nbsp;Maryke Schoonen,&nbsp;Monray E. Williams,&nbsp;Michelle Bisschoff,&nbsp;Francois H. van der Westhuizen","doi":"10.1111/eci.70114","DOIUrl":"10.1111/eci.70114","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Congenital myopathies are inherited neuromuscular disorders characterized by early-onset muscle weakness and distinct histopathological features. Although mitochondrial involvement in congenital myopathy is well recognized in its pathophysiology, oxidative phosphorylation (OXPHOS) complex dysfunction, which is associated with primary mitochondrial diseases (MD), is not. This systematic review aimed to evaluate the prevalence and characteristics of reported OXPHOS complex dysfunction in genetically confirmed congenital myopathy cases.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A systematic literature search was conducted in PubMed, Scopus and Web of Science. The search strategy was developed according to PRISMA guidelines. Two independent reviewers screened the studies for inclusion. Eligible studies reported genetically confirmed congenital myopathy cases or disease models and included diagnostic OXPHOS complex analyses via enzyme kinetic assays and/or protein/RNA expression.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 5841 studies screened, 23 publications (2009–2025) met the inclusion criteria, comprising 45 congenital myopathy cases. OXPHOS complex dysfunction was reported in 78% of these cases, including all human cases where OXPHOS enzymology was performed. Nine congenital myopathy-associated genes were involved in the cases, with <i>RYR1</i> being the most frequent. No definitive genotype–phenotype relationship was established between specific genes and affected complexes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>OXPHOS complex dysfunction in congenital myopathy appears to be more prevalent than previously recognized, challenging the traditional view that associates such dysfunction exclusively with MD. This emerging evidence suggests that mitochondrial involvement in congenital myopathy is not incidental but may represent a meaningful aspect of its pathophysiology. The potential dysregulation of OXPHOS in congenital myopathy has implications for refining diagnostic frameworks for both congenital myopathy and MD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"55 11","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/eci.70114","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral anticoagulant therapy for patients with atrial fibrillation on long-term dialysis: A network meta-analysis of 137,574 patients 长期透析房颤患者口服抗凝治疗:137,574例患者的网络荟萃分析
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-08 DOI: 10.1111/eci.70120
Yao Du, Yuwen Zeng, Sixin Xu, Qiwei Shen, Jinzhu Hu, Gregory Y. H. Lip

Background

Patients with atrial fibrillation (AF) with end-stage renal failure on renal replacement therapy are at high risk of stroke and bleeding, but the optimal oral anticoagulation (OAC) strategy is uncertain. To investigate the most effective OAC therapy for patients with AF on long-term dialysis.

Methods

PubMed, EMBASE and Web of Science databases were systematically searched from inception to 9 October 2024 to identify relevant studies on OAC strategy for patients with AF on long-term dialysis. The effectiveness outcomes were ischaemic stroke and/or systemic thromboembolism, all-cause mortality and the safety endpoint was major bleeding.

Results

The present study encompassed a comprehensive analysis of 33 studies involving a total of 137,574 patients with AF on long-term dialysis. All OACs, including warfarin (hazard ratio [HR], .963; 95% confidence interval [CI], .841–1.104), did not show a statistically significant decrease in the risk of ischaemic stroke and/or systemic thromboembolism compared to no anticoagulant therapy. Only apixaban 5 mg twice daily was associated with a lower risk of all-cause mortality compared to non-OAC use (HR, .671; 95% CI, .490–.919). Dabigatran (HR, 2.140; 95% CI, 1.734–2.642) and phenprocoumon (HR, 2.419; 95% CI, 1.241–4.713) were associated with a significantly higher risk of major bleeding than non-OAC use.

Conclusions

All OACs were not associated with a reduced risk of ischaemic stroke and/or systemic thromboembolism in patients with AF on long-term dialysis. Only apixaban 5 mg twice daily was associated with a decrease in all-cause mortality when compared with non-OAC use.

背景:接受肾脏替代治疗的房颤(AF)终末期肾衰竭患者卒中和出血风险高,但最佳口服抗凝(OAC)策略尚不确定。探讨OAC治疗AF长期透析患者最有效的方法。方法:系统检索PubMed、EMBASE和Web of Science数据库,从建立之日起至2024年10月9日,寻找房颤长期透析患者OAC策略的相关研究。有效性终点为缺血性卒中和/或全身性血栓栓塞,全因死亡率,安全性终点为大出血。结果:本研究包括对33项研究的综合分析,共涉及137,574例长期透析的房颤患者。包括华法林在内的所有OACs(危险比[HR], 0.963; 95%可信区间[CI], 0.841 -1.104)与未使用抗凝治疗相比,缺血性卒中和/或全身性血栓栓塞的风险均未显示统计学意义上的显著降低。与不使用oac相比,只有阿哌沙班5mg每日两次与全因死亡风险较低相关(HR, 0.671; 95% CI, 0.490 - 0.919)。达比加群(HR, 2.140; 95% CI, 1.734-2.642)和phenprocoumon (HR, 2.419; 95% CI, 1.241-4.713)与非oac使用的大出血风险显著升高相关。结论:在长期透析的房颤患者中,所有oac与缺血性卒中和/或全身性血栓栓塞的风险降低无关。与非oac使用相比,只有阿哌沙班5mg,每日两次与全因死亡率降低相关。
{"title":"Oral anticoagulant therapy for patients with atrial fibrillation on long-term dialysis: A network meta-analysis of 137,574 patients","authors":"Yao Du,&nbsp;Yuwen Zeng,&nbsp;Sixin Xu,&nbsp;Qiwei Shen,&nbsp;Jinzhu Hu,&nbsp;Gregory Y. H. Lip","doi":"10.1111/eci.70120","DOIUrl":"10.1111/eci.70120","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Patients with atrial fibrillation (AF) with end-stage renal failure on renal replacement therapy are at high risk of stroke and bleeding, but the optimal oral anticoagulation (OAC) strategy is uncertain. To investigate the most effective OAC therapy for patients with AF on long-term dialysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>PubMed, EMBASE and Web of Science databases were systematically searched from inception to 9 October 2024 to identify relevant studies on OAC strategy for patients with AF on long-term dialysis. The effectiveness outcomes were ischaemic stroke and/or systemic thromboembolism, all-cause mortality and the safety endpoint was major bleeding.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The present study encompassed a comprehensive analysis of 33 studies involving a total of 137,574 patients with AF on long-term dialysis. All OACs, including warfarin (hazard ratio [HR], .963; 95% confidence interval [CI], .841–1.104), did not show a statistically significant decrease in the risk of ischaemic stroke and/or systemic thromboembolism compared to no anticoagulant therapy. Only apixaban 5 mg twice daily was associated with a lower risk of all-cause mortality compared to non-OAC use (HR, .671; 95% CI, .490–.919). Dabigatran (HR, 2.140; 95% CI, 1.734–2.642) and phenprocoumon (HR, 2.419; 95% CI, 1.241–4.713) were associated with a significantly higher risk of major bleeding than non-OAC use.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>All OACs were not associated with a reduced risk of ischaemic stroke and/or systemic thromboembolism in patients with AF on long-term dialysis. Only apixaban 5 mg twice daily was associated with a decrease in all-cause mortality when compared with non-OAC use.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"55 12","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145014146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of medical educational background on the diagnostic quality of ChatGPT-4 responses in internal medicine: A pilot study 医学教育背景对内科ChatGPT-4应答诊断质量的影响:一项初步研究
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-08 DOI: 10.1111/eci.70113
Nicolò Gilardi, Massimo Ballabio, Francesco Ravera, Lorenzo Ferrando, Mario Stabile, Andrea Bellodi, Giovanni Talerico, Benedetta Cigolini, Carlo Genova, Federico Carbone, Fabrizio Montecucco, Christian Bracco, Alberto Ballestrero, Gabriele Zoppoli

This pilot study evaluated the influence of medical background on the diagnostic quality of ChatGPT-4's responses in Internal Medicine. Third-year students, residents and specialists summarised five complex NEJM clinical cases before querying ChatGPT-4. Diagnostic ranking, assessed by independent experts, revealed that residents significantly outperformed students (OR 2.33, p = .007); though overall performance was low. These findings indicate that user expertise and concise case summaries are critical for optimising AI diagnostics, highlighting the need for enhanced AI training and user interaction strategies.

本初步研究评估了医学背景对ChatGPT-4在内科诊断质量的影响。在查询ChatGPT-4之前,三年级学生、住院医师和专家总结了五个复杂的NEJM临床病例。由独立专家评估的诊断排名显示,住院医生的表现明显优于学生(OR 2.33, p = .007);尽管整体表现不佳。这些发现表明,用户专业知识和简明的案例摘要对于优化人工智能诊断至关重要,强调了加强人工智能培训和用户交互策略的必要性。
{"title":"Influence of medical educational background on the diagnostic quality of ChatGPT-4 responses in internal medicine: A pilot study","authors":"Nicolò Gilardi,&nbsp;Massimo Ballabio,&nbsp;Francesco Ravera,&nbsp;Lorenzo Ferrando,&nbsp;Mario Stabile,&nbsp;Andrea Bellodi,&nbsp;Giovanni Talerico,&nbsp;Benedetta Cigolini,&nbsp;Carlo Genova,&nbsp;Federico Carbone,&nbsp;Fabrizio Montecucco,&nbsp;Christian Bracco,&nbsp;Alberto Ballestrero,&nbsp;Gabriele Zoppoli","doi":"10.1111/eci.70113","DOIUrl":"10.1111/eci.70113","url":null,"abstract":"<p>This pilot study evaluated the influence of medical background on the diagnostic quality of ChatGPT-4's responses in Internal Medicine. Third-year students, residents and specialists summarised five complex NEJM clinical cases before querying ChatGPT-4. Diagnostic ranking, assessed by independent experts, revealed that residents significantly outperformed students (OR 2.33, <i>p</i> = .007); though overall performance was low. These findings indicate that user expertise and concise case summaries are critical for optimising AI diagnostics, highlighting the need for enhanced AI training and user interaction strategies.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"55 11","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/eci.70113","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145023036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-related differences in cardiogenic shock secondary to Takotsubo syndrome Takotsubo综合征继发心源性休克的年龄相关性差异
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-04 DOI: 10.1111/eci.70119
Marco Tomasino, Ravi Vazirani, Jorge Salamanca, Sergio Raposeiras-Roubin, Clara Fernández-Cordón, Miguel Corbí-Pascual, Oscar Vedia, Agustín C. Martín-García, Emilia Blanco-Ponce, Manuel Almendro Delia, Alberto Piserra-López, Jaime Francisco Larre Guerra, Francisco Gonzalez-Santorum, Carmen Lluch-Requerey, Marta Guillén-Marzo, Alberto Pérez-Castellanos, Francisco Ridocci-Soriano, Javier Lopez-País, Rut Andrea, Alessandro Sionis, Iván J. Núñez-Gil, Aitor Uribarri

Background

Age-related differences in Takotsubo Syndrome (TTS) have been described, but there is limited information regarding TTS patients who develop cardiogenic shock (CS).

Methods and Results

We analysed data from 408 CS-TTS patients in the RETAKO registry. Patients were stratified into three age groups: ≤50 years (9%), 51–74 years (48%), and ≥75 years (43%). In the youngest group, compared to the middle-aged and the oldest groups, patients were more likely to be male (35% vs. 16% and 14%, p = .01), have a physical trigger (65% vs. 43% and 49%, p = .04), exhibit atypical echocardiographic patterns (27% vs. 11% and 11%, p = .02), and experienced a higher incidence of ventricular arrhythmias (24% vs. 8% and 7%, p = .01). In-hospital mortality rates were 5% in younger patients, 12% in middle-aged patients, and 15% in older patients (p = .15). Older age independently predicted both in-hospital mortality (OR 2.33, 95% CI 1.05–5.17; reference: middle-aged) and 5-year mortality (HR 3.69, 95% CI 1.77–7.67), regardless of shock severity.

Conclusions

In CS-TTS, younger patients exhibit distinct clinical features but have better outcomes. Older age is associated with higher in-hospital and long-term mortality, regardless of comorbidities and shock severity. These findings underscore the need for age-specific management strategies and further research into the mechanisms underlying age-related differences in CS-TTS.

背景:Takotsubo综合征(TTS)的年龄相关差异已被描述,但关于TTS患者发生心源性休克(CS)的信息有限。方法和结果:我们分析了RETAKO登记处408例CS-TTS患者的数据。患者分为三个年龄组:≤50岁(9%)、51-74岁(48%)和≥75岁(43%)。与中年组和老年组相比,最年轻组的患者更有可能是男性(35%对16%和14%,p =。01),有物理触发(65%对43%和49%,p =。2004),表现出非典型超声心动图模式(27%对11%和11%,p =。2002年),室性心律失常发生率较高(24%比8%和7%,p = 0.01)。住院死亡率年轻患者为5%,中年患者为12%,老年患者为15% (p = .15)。无论休克严重程度如何,老年人独立预测住院死亡率(OR 2.33, 95% CI 1.05-5.17;参考:中年人)和5年死亡率(HR 3.69, 95% CI 1.77-7.67)。结论:在CS-TTS中,年轻患者表现出明显的临床特征,但预后较好。无论合并症和休克严重程度如何,年龄越大,住院死亡率和长期死亡率越高。这些发现强调了针对年龄的管理策略和进一步研究CS-TTS年龄相关差异机制的必要性。
{"title":"Age-related differences in cardiogenic shock secondary to Takotsubo syndrome","authors":"Marco Tomasino,&nbsp;Ravi Vazirani,&nbsp;Jorge Salamanca,&nbsp;Sergio Raposeiras-Roubin,&nbsp;Clara Fernández-Cordón,&nbsp;Miguel Corbí-Pascual,&nbsp;Oscar Vedia,&nbsp;Agustín C. Martín-García,&nbsp;Emilia Blanco-Ponce,&nbsp;Manuel Almendro Delia,&nbsp;Alberto Piserra-López,&nbsp;Jaime Francisco Larre Guerra,&nbsp;Francisco Gonzalez-Santorum,&nbsp;Carmen Lluch-Requerey,&nbsp;Marta Guillén-Marzo,&nbsp;Alberto Pérez-Castellanos,&nbsp;Francisco Ridocci-Soriano,&nbsp;Javier Lopez-País,&nbsp;Rut Andrea,&nbsp;Alessandro Sionis,&nbsp;Iván J. Núñez-Gil,&nbsp;Aitor Uribarri","doi":"10.1111/eci.70119","DOIUrl":"10.1111/eci.70119","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Age-related differences in Takotsubo Syndrome (TTS) have been described, but there is limited information regarding TTS patients who develop cardiogenic shock (CS).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods and Results</h3>\u0000 \u0000 <p>We analysed data from 408 CS-TTS patients in the RETAKO registry. Patients were stratified into three age groups: ≤50 years (9%), 51–74 years (48%), and ≥75 years (43%). In the youngest group, compared to the middle-aged and the oldest groups, patients were more likely to be male (35% vs. 16% and 14%, <i>p</i> = .01), have a physical trigger (65% vs. 43% and 49%, <i>p</i> = .04), exhibit atypical echocardiographic patterns (27% vs. 11% and 11%, <i>p</i> = .02), and experienced a higher incidence of ventricular arrhythmias (24% vs. 8% and 7%, <i>p</i> = .01). In-hospital mortality rates were 5% in younger patients, 12% in middle-aged patients, and 15% in older patients (<i>p</i> = .15). Older age independently predicted both in-hospital mortality (OR 2.33, 95% CI 1.05–5.17; reference: middle-aged) and 5-year mortality (HR 3.69, 95% CI 1.77–7.67), regardless of shock severity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>In CS-TTS, younger patients exhibit distinct clinical features but have better outcomes. Older age is associated with higher in-hospital and long-term mortality, regardless of comorbidities and shock severity. These findings underscore the need for age-specific management strategies and further research into the mechanisms underlying age-related differences in CS-TTS.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"56 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the comment on ‘Branched-chain amino acids and all-cause mortality in patients with liver cirrhosis, and the onset of diabetes in liver transplant recipients’ 对“肝硬化患者支链氨基酸与全因死亡率及肝移植受者糖尿病发病”评论的回应。
IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-03 DOI: 10.1111/eci.70118
Yakun Li, Robin P. F. Dullaart
{"title":"Response to the comment on ‘Branched-chain amino acids and all-cause mortality in patients with liver cirrhosis, and the onset of diabetes in liver transplant recipients’","authors":"Yakun Li,&nbsp;Robin P. F. Dullaart","doi":"10.1111/eci.70118","DOIUrl":"10.1111/eci.70118","url":null,"abstract":"","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"55 11","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Clinical Investigation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1